Due to the known sex-specific differences in cancer incidence34–36 with approximately 20% higher cancer incidence in men36, we carried out additional sex-specific analyses for associations between incretins and risk of any incident cancer, finding a borderline association between higher fasting GLP-1 and lower cancer risk only in men. This evidence concerns the gene GLP1R and cancer.